Showing results (21-30 of 84) with videos related to
Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 27, 2014
Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibitionMahmoud Toulany, Julia Mihatsch, Marina Holler, et al.Journal of Drug Targeting|September 19, 2014
Nanoparticulate carriers: an emerging tool for breast cancer therapyPriyanka Tharkar, Asad Ullah Madani, Annette Lasham, et al.Cancers|April 3, 2021
Breast Cancer Patient Prognosis Is Determined by the Interplay between TP53 Mutation and Alternative Transcript Expression: Insights from TP53 Long Amplicon Digital PCR AssaysAnnette Lasham, Nicholas Knowlton, Sunali Y Mehta, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2011
K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcsMinjmaa Minjgee, Mahmoud Toulany, Rainer Kehlbach, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2005
Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathwayMahmoud Toulany, Klaus Dittmann, Maren Krüger, et al.International Journal of Radiation Oncology, Biology, Physics|June 24, 2021
Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid TumorsKonstanze Lettau, Shayan Khozooei, Corinna Kosnopfel, et al.International Journal of Molecular Sciences|November 22, 2017
Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent MannerKatharina Mueck, Simone Rebholz, Mozhgan Dehghan Harati, et al.Cancer Research|December 4, 2016
A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq MethodologySunali Mehta, Peter Tsai, Annette Lasham, et al.Therapeutic Advances in Medical Oncology|July 27, 2011
Predictive and prognostic molecular markers for cancer medicineSunali Mehta, Andrew Shelling, Anita Muthukaruppan, et al.The Biochemical Journal|December 11, 2012
YB-1: oncoprotein, prognostic marker and therapeutic target?Annette Lasham, Cristin G Print, Adele G Woolley, et al.Pageof 9